Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Debrisoquine metabolism and lung cancer risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jan 2000

Shaw G L, Falk R T, Deslauriers J, Frame J N, Nesbitt J C, Pass H I, Issaq H J, Hoover R N, Tucker M A

Abstract excerpt

Previous reports of the association between the debrisoquine metabolic polymorphism and lung cancer risk have been conflicting. We examined the hypothesis that the genetically determined ability to metabolize debrisoquine identifies individuals at increased risk for lung cancer in a study designed to address some of the methodological criticisms of previous studies. A case-control study of 335 incident Caucasian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Disease Susceptibility

Share to Lung Neoplasms

Share to Phenotype

Share to Polymorphism, Genetic

Share to Risk Factors

Source

Identifiers

PMID: 7894323

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Debrisoquine metabolism and lung cancer risk.PMID 7894323Read ↗

Lung cancer and the debrisoquine metabolic phenotype.Semantic proximity Read ↗

Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.Semantic proximity Read ↗

Debrisoquine oxidation phenotype and susceptibility to lung cancer.Semantic proximity Read ↗

Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls.Semantic proximity Read ↗

Is there a link between debrisoquine oxidation phenotype and lung cancer susceptibility?Semantic proximity Read ↗

The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype.Semantic proximity Read ↗

A protocol for the safe administration of debrisoquine in biochemical epidemiologic research protocols for hospitalized patients.Semantic proximity Read ↗

Genetic polymorphism of CYP2D6 and lung cancer risk.Semantic proximity Read ↗

Lung tumor resection does not affect debrisoquine metabolism.Semantic proximity Read ↗

Debrisoquin oxidation genotype and susceptibility to lung cancer.Semantic proximity Read ↗

Metabolic oxidation phenotypes as markers for susceptibility to lung cancer.Semantic proximity Read ↗

Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.